Search results

Health researchers at ANSTO use world-class nuclear and isotopic techniques to undertake research and development activities to address some of the most challenging health problems.

An investment that will secure the long term sustainability of nuclear medicine supply in Australia.

The Chair of ANSTO, The Hon Dr Annabelle Bennett, AC SC, announced today that Mr Shaun Jenkinson has been reappointed as the Chief Executive Officer of ANSTO.

Timetable and Teams links

ANSTO has contributed to research on a novel therapeutic option for combatting antimicrobial-resistant Gram-negative bacteria, known as superbugs.

New screening method developed to confirm if deuteration improves metabolic stability.

ANSTO expertise focused on understanding of reduced water levels at Thirlmere Lakes in three year collaborative project

Frequently asked questions on the Mo-99 Manufacturing Facility and the ANSTO Nuclear Medicine project.

An international team led by ANSTO has been awarded a prestigious program grant from the Foundation for Australia-Japan Studies.

See details of previously published customer updates from our Health products team. 

ANSTO has contributed to a recent publication in Nature Communications Biology that represents a landmark achievement in structural biology, an understanding of protein regulation mechanisms in Mycobacterium tuberculosis (Mtb), a global health threat.

ANSTO provides a list of journal, book, technical and conference publications associated with the Australian Centre for Neutron Scattering, and the Centre for Accelerator Science.

Guidance for obtaining and maintaining human or animal ethics approval at the Australian Synchrotron.